Class Action Filed Against Celsius Holdings Over Alani Nu Health Risks
News related to:Celsius Holdings, Inc · 1 min read
Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, has filed a class action lawsuit against Celsius Holdings, Inc. (NASDAQ: CELH) and certain of its officers. The lawsuit, which seeks to recover damages on behalf of investors who purchased Celsius securities between February 21, 2025, and June 3, 2026, is based on alleged violations of federal securities laws.
According to the lawsuit, Celsius Holdings, Inc. failed to adequately disclose the cardiac risks associated with its Alani Nu products. The company is accused of targeting consumers under the age of 18, despite the known health risks associated with the products. The complaint argues that these unaddressed risks created a significant threat of potentially fatal adverse health events among consumers. As a result, the company's positive statements regarding its business, operations, and prospects were allegedly materially false and misleading.
The law firm advises investors who purchased or otherwise acquired Celsius securities during the class period to review the complaint and consider joining the lawsuit. The deadline to request appointment as lead plaintiff is November 3, 2026. Investors can visit the firm's website at bgandg.com/cases/celsius-holdings-inc-celh-class_action_lawsuit for more information or contact Peretz Bronstein, Esq., or Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC, at 917-590-0911.
Bronstein, Gewirtz & Grossman, LLC, emphasizes its role in representing investors in securities fraud class actions and shareholder derivative suits. The firm has a track record of recovering hundreds of millions of dollars for investors nationwide.
The lawsuit highlights the ongoing scrutiny of health claims made by companies and the potential legal consequences for failing to disclose critical health risks associated with products. Investors are urged to take action to protect their interests and ensure that the company's business practices adhere to securities laws.